Krebs Biochemicals and Industries has informed that it enclosed copies of the Unaudited Financial Results for the quarter and nine months ended 31st December 2024 approved in the Board Meeting held on 4th February 2025 and published on 5th February 2025 in Business Standard (English) and Prajasakti (Telugu).
The above information is a part of company’s filings submitted to BSE.